Aytu Biopharma (AYTU) Net Income (QoQ) (2011 - 2025)
Aytu Biopharma (AYTU) Net Income (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 22.92 Mn | -3.80 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 14.81% |
| Mar 31, 2025 | -56.10% |
| Dec 31, 2024 | -67.72% |
| Sep 30, 2024 | 130.75% |
| Jun 30, 2024 | -106.84% |
| Mar 31, 2024 | 28.61% |
| Dec 31, 2023 | -29.68% |
| Sep 30, 2023 | 73.67% |
| Jun 30, 2023 | 65.88% |
| Mar 31, 2023 | -7.58% |
| Dec 31, 2022 | -854.78% |
| Sep 30, 2022 | -110.07% |
| Jun 30, 2022 | 113.06% |
| Mar 31, 2022 | -361.47% |
| Dec 31, 2021 | 58.54% |
| Sep 30, 2021 | -48.63% |
| Dec 31, 2020 | -121.20% |
| Sep 30, 2020 | 40.87% |
| Jun 30, 2020 | -36.57% |
| Mar 31, 2020 | 1.51% |